10/28/2026
Pharma giants invest billions in psychedelics despite hurdles
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
Topic archive
ataibeckley
2 stories
7/17/2026
Eli Lilly acquires 5-MeO-DMT developer for $3.8B
Pharmaceutical giant expands into psychedelic research with major acquisition.